bisphosphonates - malecare.org

On The Horizon- Coming Soon – Radium-223 (Alpharadin) A Bone Targeted Treatment for Advanced Prostate Cancer that Extends Life

At the recent European Multidisciplinary Cancer Congress in Stockholm, Dr Chris Parker from The Royal Marsden Hospital presented results of the phase 3 ALSYMPCA trial that showed both delayed time to first skeletal-related event (SRE) AND an overall survival (OS) benefit for those men with advanced prostate cancer taking radium-223 (Alpharadin). The real significance of [...]

By Malecare|2011-10-04T15:33:19-04:00October 4th, 2011|abiraterone acetate, Advanced Prostate Cancer, Alpharadin (radium-223), bisphosphonates, Cabazitaxel, Chemo Therapy Failure, Clinical Trials, Clinical Trials, denosumab - Xgeva, Drugs & Treatments, On The Horizon, Uncategorized, Zometa|1 Comment

Should Bisphosphonates Use Be Limited- An FDA Panel Waffles on Limiting Duration

A recent meeting of an FDA advisory committee has asked wants the FDA to limit the duration of bisphosphonate therapy for treatment of osteoporosis, but the committee could not agree on a time limit to recommend. […]

By Malecare|2011-09-13T10:46:54-04:00September 13th, 2011|Advanced Prostate Cancer, bisphosphonates, Bone Mineral Density, Drugs & Treatments, FDA, Uncategorized, Understanding APC, Zometa|0 Comments

On The Horizon – Xgeva (denosumab) To Prevent or Slow Down Bone Mets

Yesterday, Amgen announced that it had submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) to expand its license for XGEVA® (denosumab) to treat men with castrate-resistant prostate cancer to reduce the risk of developing bone metastases. If approved, XGEVA would be the first therapy licensed to prevent or [...]

By Malecare|2011-06-27T23:08:22-04:00June 27th, 2011|Advanced Prostate Cancer, bisphosphonates, Clinical Trials, Clinical Trials, denosumab - Prolia, denosumab - Xgeva, Drugs & Treatments, FDA, Metastases, On The Horizon, Uncategorized, Understanding APC|0 Comments

A Video on Bone Metastases & Zometa

I recently made a video with Dr. James Mckiernan of Columbia Presbyterian Hospital in New York City on the use of Zometa (zoledronic acid) to combat bone metastases in advanced prostate cancer that is castrate resistant. Novartis Oncology, the makers of Zometa, sponsored the video and it was produced on the Wego Health web page. [...]

By Malecare|2020-02-04T08:52:57-05:00May 2nd, 2011|Advanced Prostate Cancer, bisphosphonates, Drugs & Treatments, General Information, Me, Uncategorized, Understanding APC, Zometa|2 Comments

Should Men on ADT Take Calcium and Vitamin D Supplementation?

As usual with prostate cancer there is no general agreement about whether or not men who are on a hormone blockade (ADT) to treat prostate cancer should be taking calcium and vitamin D supplements, however there does seem to be some consensus that they should. Given that there are geographic and seasonal variations in vitamin [...]

By Malecare|2011-04-27T10:46:54-04:00April 27th, 2011|Advanced Prostate Cancer, bisphosphonates, denosumab - Prolia, Diet and Supplements, Drugs & Treatments, General Information, Uncategorized, Understanding APC, Zometa|1 Comment